MAP2 and depressive symptom measurement: Regarding α‐tubulin PTMs, it is still not clear how treatment with PME prevents their reported alterations in animals models of depression; however, a positive correlation between the MT‐binding of MAP2 and the increase of Acet‐Tub has already been demonstrated.95